Life Sciences Archives - Page 6 of 21 - Becker's Hospital Review

CDC awards vaccine, autism contract | St. Jude 3D printing drug compounds | Cardiology enters GLP-1 era | MSK to cut 2% of jobs

September 17, 2025 1. CDC to award no-bid contract for vaccine, autism research Full story 2. St. Jude tests 3D printing for drug formulations Full story 3. Too many metrics & not enough progress: Reset your ops strategy with this…

GLP-1s deemed essential | Repurposed drugs target cancer 'sleeper cells' | Novartis inks $1.4B heart drug deal | HHS outlines children's health plan

September 10, 2025 1. Repurposed drugs successfully target cancer 'sleeper cells': 5 study notes Full story 2. WHO adds GLP-1s to essential medications list Full story 3. UCSF Health increased nurse satisfaction + workload equity in infusion. See what drove…

Trump demands COVID data | Pfizer lays off 100 | GLP-1s cut heart failure risks | FDA approves Alzheimer's drug

September 3, 2025 1. Pfizer lays off 100 in Washington state Full story 2. Trump demands COVID 'drug' data from pharmaceutical companies Full story 3. Still waiting for AI results? These 3 case studies show what works. Details here. 4. FDA…

3 new drugs to watch | GLP-1s' impact on cancer care | AbbVie to buy drug for $1.2B | Eli Lilly's GLP-1 cuts weight by 10% | Pharma merger forms $6B company

August 27, 2025 1. GLP-1s and cancer: What to know Full story 2. 3 new drugs to watch: Optum Full story 3. CEOs and CFOs from Cleveland Clinic, Intermountain Health and Geisinger join 375+ speakers dissecting capital allocation, partnership models…

Eli Lilly accused of bribing providers | Wegovy gets OK to treat liver disease | Ozempic price halved | AstraZeneca launches 1st at-home flu shot

August 20, 2025 1. FDA approves Wegovy to treat liver disease Full story 2. Texas accuses Eli Lilly of bribing providers to prescribe Mounjaro, other drugs Full story 3. Build a back office that bends — not breaks — when…

Eli Lilly GLP-1 pill shines in trial | Brain tumor, ketamine drugs approved | GSK gets $370M in patent settlement | FDA vaccine chief returns

August 13, 2025 1. FDA approves brain tumor drug targeting new mutation Full story 2. Eli Lilly's daily GLP-1 pill sheds 27 pounds in trial Full story 3. Underresourced and overburdened: How rural hospitals can better support clinical teams here.…

RFK Jr. cancels $500M in vaccine contracts | Blood cancer therapy denied approval | CMS floats GLP-1 coverage | FDA's top vaccine, gene therapy official resigns

August 6, 2025 1. FDA denies approval for Regeneron blood cancer therapy Full story 2. RFK Jr. cancels $500M in mRNA vaccine contracts Full story 3. Stop overtime creep: Find efficiency tips from Baptist MD Anderson's team here. 4. CMS…

Roche halts gene therapy shipments | Blocks to NIH grants walked back | Patient death not tied to gene therapy | Sun Pharma fails inspection

July 30, 2025 1. Roche pauses gene therapy shipments Full story 2. White House walks back NIH grant blocks Full story 3. Less paperwork, more patient care — how AI is transforming the clinician experience: here. 4. Death of 8-year-old…

NIH, FDA cuts threaten drug approvals | Sarepta halts gene therapy shipments | Pfizer to ration syphilis treatment | Potential cancer drug-Alzheimer's connection

July 23, 2025 1. Cuts to NIH, FDA could slash drug approvals: 5 notes Full story 2. Sarepta reverses course, halts gene therapy shipments following FDA request Full story 3. Real-time triage, smarter workflow. Inspira Health's ED turnaround and what…

US drugmaker ends operations | GLP-1s may raise testosterone | CVS faces $949M judgement | HHS layoffs resume

July 16, 2025 1. US drugmaker shutters operations, recalls medications Full story 2. AstraZeneca drug lowers blood pressure: Study Full story 3. Shared cleaning roles are slowing care and adding risk. See what top systems do instead here. 4. HHS…